Abstract. Background: Results from some epidemiologic studies have suggested that aspirin use may reduce risk of pancreatic cancer, but the evidence remains .
Results: Participants were classified according to history of aspirin use. In a multivariable analysis, the risk of pancreatic cancer was not associated with current .
According to a Chinese-based study led by Dr. Harvey Risch, it is possible that daily low-dose aspirin may.
People who take low-dose aspirin for more than 10 years might be reducing their risk for pancreatic cancer, a new study suggests.